Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Optics Express|July 13, 2011
Color filters including infrared cut-off integrated on CMOS image sensorLaurent Frey, Pascale Parrein, Jacques Raby, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Utility of serum HER2 extracellular domain assessment in clinical decision making: pooled analysis of four trials of trastuzumab in metastatic breast cancerSiân Lennon, Claire Barton, Ludger Banken, et al.International Journal of Radiation Oncology, Biology, Physics|January 26, 2005
Infrastructure of radiation oncology in France: a large survey of evolution of external beam radiotherapy practiceSophie Ruggieri-Pignon, Thierry Pignon, Michel Marty, et al.Investigational New Drugs|September 19, 2007
Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumorsCatherine Delbaldo, Eric Raymond, Karina Vera, et al.Obesity Surgery|March 16, 2007
A nationwide survey on bariatric surgery in France: two years prospective follow-upArnaud Basdevant, Michel Paita, Marie-Héléne Rodde-Dunet, et al.Annals of Surgery|November 29, 2007
Predictive factors of outcome after gastric banding: a nationwide survey on the role of center activity and patients' behaviorJean-Marc Chevallier, Michel Paita, Marie-Hélène Rodde-Dunet, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 6, 2013
Expansion of CMV-mediated NKG2C+ NK cells associates with the development of specific de novo malignancies in liver-transplanted patientsAbla Achour, Florence Baychelier, Caroline Besson, et al.Journal of Vascular Surgery|December 19, 2003
Use of abdominal aortic endovascular prostheses in France from 1999 to 2001Jean-Baptiste Ricco, Olivier Goëau-Brissonnière, Marie-Hélène Rodde-Dunet, et al.Bulletin Du Cancer|November 28, 2008
[Decision making process in oncology: rationale and delineation of a composite index of relative antitumoral efficacy (In-RATE)]Michel Marty, Jean-Yves Blay, Jean Trédaniel, et al.Pageof 6